scispace - formally typeset
F

Fabio Penna

Researcher at University of Turin

Publications -  82
Citations -  10973

Fabio Penna is an academic researcher from University of Turin. The author has contributed to research in topics: Cachexia & Wasting. The author has an hindex of 34, co-authored 76 publications receiving 8809 citations. Previous affiliations of Fabio Penna include Sapienza University of Rome & University of Barcelona.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Role of Inflammation in Muscle Homeostasis and Myogenesis.

TL;DR: An overview of skeletal muscle intracellular pathways determining fiber size is given, and the evidences supporting the role of inflammation in impairing muscle homeostasis and myogenesis, potentially determining muscle atrophy are discussed.
Journal ArticleDOI

Molecular and cellular mechanisms of skeletal muscle atrophy: an update.

TL;DR: The multifacetted therapeutic approach that is currently employed to prevent the development of muscle wasting and to counteract its progression is focused on, which includes adequate nutritional support, implementation of exercise training, and possible pharmacological compounds.